Loading...

The current price of CLBT is 18.39 USD — it has decreased -2.28 % in the last trading day.
Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world.
Wall Street analysts forecast CLBT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CLBT is 24.83 USD with a low forecast of 23.00 USD and a high forecast of 28.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Cellebrite DI Ltd revenue for the last quarter amounts to 126.03M USD, increased 17.94 % YoY.
Cellebrite DI Ltd. EPS for the last quarter amounts to 0.08 USD, decreased -108.08 % YoY.
Cellebrite DI Ltd (CLBT) has 1167 emplpoyees as of December 15 2025.
Today CLBT has the market capitalization of 4.60B USD.